Introduction
============

*Candida auris* is an emerging multidrug-resistant (MDR) yeast pathogen that causes healthcare-associated invasive infections. There is growing evidence suggesting that *C. auris* may persistently colonize the hospital environment and multiple body sites of patients, leading to high transmissibility, and prolonged outbreaks ([@B30]; [@B36]). Indeed, we are encountering for the first time an MDR yeast pathogen with a high capacity to cause clusters of invasive infections in medical centers around the world ([@B16]; [@B20]; [@B7], [@B6]; [@B3]; [@B27]; [@B21]; [@B22]). *C. auris* fungemia results in crude mortality rates ranging from 32 to 66%, depending on the patient's underlying conditions, geographic region, and age as well as the clinical management of the infection ([@B20]; [@B28]; [@B6]; [@B3]; [@B30]; [@B22]; [@B36]).The description of *C. auris* fungemia outbreaks worldwide illustrates the dramatically increased need to develop new strategies to prevent and control infections due to this multiresistant pathogen. Despite the large number of papers addressing *C. auris* infections published since 2009, few have attempted to investigate the pathogenicity and virulence of this new human pathogen. Here, we review all papers addressing biological factors that affect the pathogenicity of *C. auris*.

What We Have Learned From Comparative Genomics of *C. auris*?
=============================================================

*C. auris* was first described after it was isolated from the ear canal of a 70-year-old Japanese woman at Tokyo Metropolitan Geriatric Hospital in Japan ([@B29]). After this report, a retrospective review of *Candida* strain collections revealed that the earliest known strain of *C. auris* dates back to 1996 in South Korea ([@B16]). However, it is unknown why *C. auris* has only recently emerged in a wide variety of locations. Based on whole genome sequencing (WGS), four different clades of *C. auris* have been described by region (East Asian, South Asian, African, and South American). Moreover, analyses of SNPs identified by WGS and multilocus sequence typing (MLST) have shown low genetic diversity between isolates within each *C. auris* clade. These results indicate a high degree of clonality within clades and suggest the independent, nearly simultaneous emergence of the four populations on three continents ([@B21]).

The complete genome of *C. auris* was only recently investigated ([@B5]; [@B31], [@B32]), and we are far from fully understanding of the role of different genes in the pathogenicity and virulence of this emerging pathogen. The main problem is that the *C. auris* genome sequence contains many uncharacterized and hypothetical proteins, and it is unclear whether these proteins are involved in species-specific characteristics that promote its aggressiveness as a pathogen ([@B5]). *C. auris* is closely related to three other rare *Candida* species -- *Candida haemulonii*, *Candida duobushaemulonii*, and *Candida pseudohaemulonii* -- in the family Metschnikowiaceae, along with more common *Candida lusitaniae* ([@B4]).

Initial analyses of the *C. auris* genome suggest that 40% of *C. auris* proteins are orthologous to those of *C. lusitaniae* ([@B32]). Considering the limited susceptibility of *C. lusitaniae* to amphotericin B and *C. haemulonii* to amphotericin B and azoles ([@B16]; [@B9]), this orthology suggests that *C. auris* shares some genetic characteristics with both species that may have helped it become resistant to multiple antifungal drugs. Indeed, a significant portion of the *C. auris* genome encodes transporter genes and protein kinases, such as the ABC and MFS transporter families, and a number of zinc cluster transcription factor orthologs such as *TAC1* (29% similarity with *Candida albicans*), which may facilitate acquisition of drug resistance ([@B32]).

By comparing the *C. auris* genome with that of *C. albicans* that is well annotated and well-studied we may suggest that C. *auris* genome harbors genes that are well-characterized as virulence factors in other *Candida* species, including genes for biofilm formation, proteinases, lipases, phospholipases, adhesins, secreted aspartyl proteases and transporters belonging to the ABC and major facilitator superfamily (MDR transcription factors) which are involved with azole resistance ([@B5]).

Phenotypic Traits and Implications for Pathogenicity
====================================================

Phenotypic switching and morphogenesis are well-known virulence attributes of *C. albicans* ([@B26]). Although micromorphological studies of *C. auris* colonies suggest that this pathogen does not produce germ tubes, pseudohyphae or chlamydospores ([@B20]; [@B6]; [@B2]; [@B37]), this yeast may present pseudohyphae-like forms under high-salt stress ([@B37]) and, occasionally, in the biofilm community ([@B33]).Pseudohyphae-like forms are characterized by rudimentary growth, with an elongated shape and incomplete cell division ([@B33]; [@B37]). Indeed, comparative genome analyses have confirmed that *C. auris* and closely related species do not have two genes, candidalysin (*ECE1*) and hyphal cell wall protein (*HWP1*), both of which are highly expressed in *C. albicans* and the transcription of both is strongly associated with hyphal formation ([@B23]).

In this scenario, *C. auris* fails to form chlamydospores after growth on cornmeal agar when incubated for 3 days at 30°C and does not germinate when incubated with fetal bovine serum (FBS). This fact was confirmed in the *Galleria mellonella* model of infection of *C. auris*, during which the isolates did not undergo significant filamentation at 18 h or at any time post infection ([@B2]).

Growth curve analyses for *C. auris* and *C. albicans* isolates demonstrate that the two *Candida* species have similar growth patterns, reaching the stationary phase within approximately 20 h ([@B19]). An interesting observation regarding the growth of *C. auris* is that certain isolates grow in clumps (i.e., budding occurs, but daughter cells are not released), which results in large aggregates of organisms that cannot be easily disrupted *in vitro* ([@B2]). These isolates are called "aggregate" strains, and certain aggregate strains are too large for *G. mellonella* larval inoculation, hindering accurate yeast cell counting. To overcome this limitation, homogeneous inoculum preparations have been obtained after allowing the initial suspension of fungal cells to settle for 10 min followed by removal of the supernatant containing individual yeast cells for infecting larvae ([@B2]). Based on this protocol, it was possible to compare the pathogenicity of aggregating and non-aggregating strains of *C. auris* with other yeast species. The results demonstrated strain-specific variability in behavior, with the aggregate-forming isolates of *C. auris* exhibiting significantly reduced pathogenicity compared to their non-aggregating counterparts ([@B2]). Moreover, when infected *G. mellonella* larvae were dissected, large numbers of individual budding yeast cells of non-aggregating strains of *C. auris* were found inside phagocytes. In addition, the larvae inoculated with individual yeast cells prepared from aggregate-forming strains of *C. auris* exhibited large aggregates of *C. auris* cells, with few individual yeast cells, indicating that the ability to produce large aggregates had been maintained *in vivo* ([@B2]). Yeast cell aggregates were also observed in the kidneys of mice infected with *C. auris,* suggesting that aggregation might be a mode of immune evasion and persistence in tissues, which warrants further investigation ([@B1]).

Tolerance to Thermic and Osmotic Stresses
=========================================

Survival and growth at physiologic temperature are prerequisites for microbial invasion and pathogenicity. *C. auris* exhibits thermotolerance, growing optimally at 37°C and maintaining viability up to 42°C. In addition, this pathogen is salt tolerant, and cells aggregate into large, difficult-to-disperse clusters, which may promote persistence in the hospital environment ([@B29]; [@B2]).

The ability of *C. auris* isolates to grow at 37°C and 40°C appears to be similar to that of *C. albicans*, and certain isolates also grow at 42°C ([@B1]). Other authors have confirmed that *C. auris* can grow at high temperature (40°C) and salinity (10%wt/vol) when cultured in Sabouraud (SAB) or yeast nitrogen base (YNB) broth with dulcitol or mannitol as the carbon source ([@B38]).

[@B37] examined the morphology of *C*. *auris* on the rich media YPD and YPD plus 10% NaCl, with a round appearance on the former medium but an elongated shape on the latter. Interestingly, a small portion of highly elongated and pseudohyphae-like forms were observed when grown on YPD plus 10% NaCl ([@B37]). These results suggest that high-salt stress may result in incomplete cell division, leading to the formation of pseudohyphae-like forms. So far, the molecular mechanism related to this phenotype of *C. auris* has not yet been investigated.

Importance of Lytic Enzymes for Fungal Invasiveness
===================================================

The production of phospholipases and proteinases has been recognized as relevant for *Candida* pathogenicity in the human host, helping in the adherence to and invasion of host cells ([@B26]). Hydrolases are the largest group of enzymes (42%) found in the *C. auris* (strain 6684) genome, followed by transferases (25%) and oxidoreductases (19%) ([@B5]). Furthermore, comparative genome analyses have revealed similar numbers of lipases in the *C. auris* relative to those of C. *albicans* and *C*. *dubliniensis* ([@B23]). The ability to produce lytic enzymes has been demonstrated in *C. auris* isolates, and the production of these enzymes is strain dependent ([@B18]; [@B19]).

An *in vitro* study evaluating *C. auris* isolates from different geographical regions showed that 37.5% of the tested strains (6/16 isolates) exhibited phospholipase activity and that 64% (9/14 isolates) were positive for proteinase ([@B19]). Similarly, most strains displayed hemolysin activity, conferring a high capacity for iron acquisition, growth, and invasiveness leading to widespread infection ([@B35]; [@B18]).

In fact, a recent study conducted by [@B37] demonstrated that the level of aspartyl proteinase (Saps) secreted by *C. auris* isolate at 42°C was higher than that exhibited by *C. albicans* at the same temperature ([@B37]). These findings suggest that *C. auris* isolates are not only well adapted to temperature stress but also maintain their pathogenicity at higher temperatures.

*C. auris* and Its Alarming Ability to Persistently Colonize Human Host and the Environment
===========================================================================================

Studies have demonstrated the ability of *C. auris* to colonize and spread throughout hospital environments. One of the most alarming characteristics of *C. auris* is the ability of this yeast to adhere to and persist on abiotic surfaces, including dry and moist surfaces, bedding material, floors, sinks and beds, as well as human skin, ears, and nasal cavities ([@B30]; [@B25]; [@B36]; [@B38]). In one study, the survival of eight *C. auris* isolates was compared with other *Candida* species on dry or moist surfaces for up to 7 days, with the recovery of *C. auris* being similar to that of other *Candida* species, vancomycin-resistant *Enterococcus* (VRE), methicillin-resistant *Staphylococcus aureus* (MRSA), and carbapenem-resistant Enterobacteriaceae (CRE) ([@B25]).

Moreover, the capacity of *C. auris* to persist and colonize the plastic surfaces of medical devices was compared with that of *Candida parapsilosis* ([@B38]) using two complementary independent methods: culture \[as measured by colony-forming units (CFU)\] and solid-phase cytometry (which detects viability, as measured by esterase activity) ([@B34]). For CFU determination, *C. auris* and *C. parapsilosis* suspensions of 5 × 10^6^ cells per mL were applied to dried plastic surfaces and followed to grow for up to 28 days. *C. auris* and *C. parapsilosis* were viable for at least 14 and 28 days, respectively; however, viable *C. auris* was detected for longer periods than previously observed by quantitative culturing. When solid-phase cytometry was used to assess individual cells for viability for longer periods of time, the results indicated that the cells entered into a viable non-culturable state, and more viable *C. auris* than *C. parapsilosis* cells were detected at all time points ([@B38]).Overall, the adherence of *C. auris* to medical devices may play a role in the development of catheter-related fungemia. In contrast to *C. albicans, C. auris* exhibits minimal ability to adhere to silicone elastomer ([@B19]).

Biofilm Production and Impact on Antifungal Resistance
======================================================

Biofilms are a common form of microbial growth that are crucial for the development of a broad spectrum of infections in the human host and also for defending pathogens from phagocytes and antimicrobial drugs ([@B11]). Seven highly conserved genes (*PLB3, IFF4, PGA52, PGA26, CSA1, HYR3,* and *PGA7*) are upregulated during biofilm production across isolates representative of *C. auris*, *C. haemulonii*, *C. duobushaemulonii*, and *C. pseudohaemulonii*. The same proteins are associated with biofilm production and mechanisms of antifungal resistance in *C. albicans* strains ([@B15]). As documented with other *Candida* species ([@B12]), there is a large intra-specific variation in the capacity of biofilm production by *C. auris.* Initial investigation with fifteen *C. auris* isolates cultured from ear specimens failed to detect any biofilm production ([@B24]). Later, [@B19] performed a comparative study to assess biofilm production by two isolates of *C. auris* and one isolate of *C. albicans* using silicone elastomer as a substrate. Quantification of the biofilms was performed using a colorimetric metabolic assay (to measure mitochondrial dehydrogenase activity-XTT) and dry weight analysis (to measure total biofilm mass). During this assay, the authors were able to detect *C. auris* biofilm production that was composed of yeast cells adhering to the catheter material. In contrast, the *C. albicans* biofilm presented a highly heterogeneous architecture composed of yeast cells and hyphae embedded within the extracellular matrix. Moreover, the *C. auris* biofilms, unlike the *C. albicans* biofilms, displayed a limited amount of extracellular matrix ([@B19]).

Recently, a comparative study was performed to evaluate the production of biofilm by isolates of *C. albicans, Candida glabrata,* two non-aggregating strains of *C. auris* and two aggregating strains of *C. auris.* The authors used 96-well polystyrene microtiter plates and measured total fungal biomass using a crystal violet assay. The results showed the greatest biofilm mass for *C. albicans*, followed by *C. auris* and *C. glabrata.* The *C. auris* biofilm was predominately composed of budding yeasts and occasional pseudohyphae ([@B33]). In the same study, the susceptibility of *C. auris* biofilms to drugs was assessed, with micafungin and caspofungin being ineffective against biofilms "*in vitro*" and requiring \> 32 mg/L to inhibit sessile cells ([@B33]).

Virulence of *C. auris* in Animal Models
========================================

A comparative study of virulence exhibited by *C. auris* and *C. haemulonii* isolates was performed in a mouse model of hematogenous-disseminated candidiasis after immunosuppression with cyclophosphamide (150 mg/kg intraperitoneally). The *C. haemulonii* isolates were found to be completely non-virulent, with 100% of the mice surviving at 12 days after inoculation and no visible signs of illness. In contrast, inoculation with *C. auris* resulted in rapid death, with only 20% survival at 5 days after infection ([@B23]). Another comparative study of *Candida* spp. virulence using an immunocompetent murine model of disseminated infection showed high virulence of *C. albicans* isolates, followed by *C. auris*, *C. glabrata,* and *C. haemulonii* ([@B10]). In this study, the animals were challenged with 10^5^ CFU/mouse injected into the lateral tail vein, and death rates were recorded up to 30 days post-infection. Mice infected with *C. albicans* exhibited 20% survival, with a median survival time (MST) of 13 days, where as mice infected with *C. auris* showed 30--40% survival until the end of the experiment, with an MST of 16--17 days post-infection ([@B10]).

The virulence of a single *C*. *auris* isolate obtained from a Chinese fungemic patient was recently evaluated in a mouse model of *Candida* systemic infection. Inoculum preparations of 1 × 10^6^CFU/ml of *C*. *albicans* (SC5314) and 1 × 10^7^CFU/ml *C. auris* were injected via the tail vein, with all animals infected with *C. albicans* dying by the 6th day post-infection but no animal infected with *C. auris* dying during the same period ([@B37]).

Due to economic and especially ethical issues, the scientific community has in the last decade limited the use of mammalian infection models to study the virulome of fungi ([@B17]). Driven by the need for validating alternative models to replace mammalian systems, invertebrate organisms, such as *G. mellonella* and *C. elegans*, have been extensively used as mini-hosts for studying the virulence attributes and host response of *Candida* infections ([@B8]).

Within this context, [@B2] developed a model of *G. mellonella* fungal infection using an inoculum solution of 1 × 10^6^ yeast cells of *C. auris, C. albicans* and *Candida* *tropicalis* isolates, whereby it was possible to demonstrate that *C. albicans* and *C. tropicalis* exhibit significantly higher virulence in terms of the kinetics of larval death and number of larvae killed ([@B2]). In accordance with other publications, these researchers found that *C. auris* isolates were not able to develop significant pseudohyphae into tissues of infected larvae ([@B20]; [@B7]; [@B14]; [@B2]). [@B37] also confirmed that the Chinese *C. auris* strain exhibits reduced virulence in *G*. *mellonella* larva compared to a *C. albicans* isolate. Overall, compared to *C. glabrata*, *C. auris* strains are usually more virulent in animal models.

Investigation of the immune response to *C. auris* using the Zebrafish model of invasive candidiasis revealed a recruitment of approximately 50% less neutrophils in response to *C. auris* infection when compared to *C. albicans* ([@B13]). Moreover, *in vitro* human neutrophils were co-cultured with *Candida* cells (2 × 10^7^ cells) for 4 h and fungal viability was measured. Neutrophils inhibited *C. albicans* growth by 75%; in contrast, the burden of *C. auris* was not impacted replicating beyond the initial inoculums, showing very little killing of *C. auris* by neutrophils. Using fluorescence microscopy, they analyzed neutrophil-*Candida* interactions, and at 1 h, very few neutrophils (15%) were either engulfing or adherent to co-incubated *C. auris* cells. In contrast, 50% of neutrophils exhibited some activity against *C. albicans.* These findings suggest that neutrophils are more able to engage and kill *C. albicans* over *C. auris* isolates ([@B13]). Viability of neutrophils co-cultured with *C. albicans* decreased by half, while upon exposure to *C. auris,* almost all neutrophils remained viable. The production of neutrophils extracellular traps (NETs) in response to *C. auris* exposition was measured by scanning electron microscopy. It was found that neutrophils engaging in phagocytosis or releasing NETs were rarely observed after exposition to *C. auris*. Furthermore, quantifying NET formation showed that *C. auris* did not trigger free DNA release, consistent with the lack of NET production observed in microscopy experiments ([@B13]).

Taking together data provided by experimental models using mice and invertebrate animals, we may conclude that *C. auris* is certainly less virulent than is *C. albicans*. Nonetheless, *C. auris* is significantly more virulent than are *C. glabrata* and *C. haemulonii* ([@B10]) and other species of *Candida* also considered to be resistant to multiple drugs. Indeed, *C. auris* was able to induce systemic infection and mortality rates higher than 50% in 2 of 3 studies investigating its virulence in a mouse model ([@B1]; [@B10]; [@B37]). Despite limited virulence when compared to *C. albicans*, *in vitro* assays conducted with human neutrophils showed that *C. auris* is less effective than *C. albicans* in triggering neutrophils engulfment and NET production.

Final Comments and Future Directions
====================================

Although animal studies indicate that *C. auris* has reduced pathogenicity and virulence compared to *C. albicans*, this emerging pathogen appears to be far more able to induce systemic infection and mortality than other potential MDR yeast pathogens, such as *C. glabrata* and *C. haemulonii* ([@B10]). This finding is likely to be related to the tolerance of *C. auris* strains to osmotic and high-temperature stress as well as to its ability to produce several lytic enzymes and biofilm ([@B1]; [@B38]).

The complete genome sequence of *C. auris* is available ([@B5]; [@B31]; [@B21]), and it is currently possible to design experiments to better characterize the molecular mechanisms responsible for the capability of this pathogen to readily become resistant to multiple antifungal drugs and to determine the presence of genes related to pathogenicity and virulence factors. An important limitation of virulence analyses based on clonal strains cultured from patients during outbreaks is that it remains unclear whether such findings may be safely extrapolated to all isolates of the species or whether they are only representative of biological properties exhibited by a few clonal strains.

An additional point that deserves more attention is the characterization of adhesins and other molecules responsible for the capability of *C. auris* to persistently colonize abiotic and biotic surfaces. Indeed, this pathogen is able to survive and persist under different environmental conditions, including on dry materials, bedding material, floors, sinks and beds, and it exhibits tolerance to temperature and osmotic stresses ([@B1]; [@B38]).

In summary, our review shows that *C. auris* expresses several virulence traits including genes that are well-characterized in other *Candida* species, including genes for biofilm formation, proteinases, lipases, phospholipases, adhesins, secreted aspartyl proteases, and transporters which are involved with azole resistance. Despite exhibiting less virulence than *C. albicans* isolates, recent findings suggest that *C. auris* fails to activate the innate immune response and production of NETs by human neutrophils, what certainly may play a role in the high mortality associated to this infection.
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